Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediChain was a UK digital health company focused on blockchain-based management of medical records, telemedicine, and AI-enabled diagnostic tools. The business was founded in 2018 and promoted products for secure patient-controlled health data sharing, along with diagnostic technologies including COVID-19-related blood-test-based analysis and smartphone-enabled blood analysis. It appears to have operated as a health technology platform rather than a therapeutics developer, with no evidence of a traditional drug pipeline. The company is healthcare-related, but not a biotech or pharma company in the usual drug-development sense. UK corporate records indicate that MEDICHAIN LTD was dissolved on July 16, 2024, so it does not appear to be an active operating company today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediChain.